×

3-3-di-substituted-oxindoles as inhibitors of translation initiation

  • US 7,737,172 B2
  • Filed: 08/09/2006
  • Issued: 06/15/2010
  • Est. Priority Date: 02/13/2004
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating cancer in a human or non-human mammal in need thereof, the method comprising administering to the human or non-human mammal a compound of formula III

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×